Altimmune Management
Management criteria checks 2/4
Altimmune's CEO is Vipin Garg, appointed in Nov 2018, has a tenure of 6.08 years. total yearly compensation is $5.48M, comprised of 11.3% salary and 88.7% bonuses, including company stock and options. directly owns 0.41% of the company’s shares, worth $2.66M. The average tenure of the management team and the board of directors is 4.1 years and 5.3 years respectively.
Key information
Vipin Garg
Chief executive officer
US$5.5m
Total compensation
CEO salary percentage | 11.3% |
CEO tenure | 6.1yrs |
CEO ownership | 0.4% |
Management average tenure | 4.1yrs |
Board average tenure | 5.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$104m |
Jun 30 2024 | n/a | n/a | -US$101m |
Mar 31 2024 | n/a | n/a | -US$93m |
Dec 31 2023 | US$5m | US$620k | -US$88m |
Sep 30 2023 | n/a | n/a | -US$78m |
Jun 30 2023 | n/a | n/a | -US$81m |
Mar 31 2023 | n/a | n/a | -US$85m |
Dec 31 2022 | US$3m | US$580k | -US$85m |
Sep 30 2022 | n/a | n/a | -US$87m |
Jun 30 2022 | n/a | n/a | -US$97m |
Mar 31 2022 | n/a | n/a | -US$102m |
Dec 31 2021 | US$3m | US$566k | -US$97m |
Sep 30 2021 | n/a | n/a | -US$84m |
Jun 30 2021 | n/a | n/a | -US$68m |
Mar 31 2021 | n/a | n/a | -US$60m |
Dec 31 2020 | US$1m | US$514k | -US$49m |
Sep 30 2020 | n/a | n/a | -US$43m |
Jun 30 2020 | n/a | n/a | -US$36m |
Mar 31 2020 | n/a | n/a | -US$22m |
Dec 31 2019 | US$815k | US$500k | -US$21m |
Sep 30 2019 | n/a | n/a | -US$42m |
Jun 30 2019 | n/a | n/a | -US$34m |
Mar 31 2019 | n/a | n/a | -US$40m |
Dec 31 2018 | US$2m | US$44k | -US$42m |
Compensation vs Market: Vipin's total compensation ($USD5.48M) is above average for companies of similar size in the UK market ($USD1.46M).
Compensation vs Earnings: Vipin's compensation has increased whilst the company is unprofitable.
CEO
Vipin Garg (66 yo)
6.1yrs
Tenure
US$5,482,089
Compensation
Dr. Vipin K. Garg, Ph D., has been the President, Chief Executive Officer and Director of Altimmune, Inc. since November 30, 2018. Dr. Garg joined Altimmune in November 2018 with over three decades of expe...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 6.1yrs | US$5.48m | 0.41% $ 2.7m | |
Chief Medical Officer | 5.4yrs | US$2.24m | 0.077% $ 502.2k | |
Chief Business Officer | 1.9yrs | US$2.94m | 0.021% $ 133.5k | |
Chief Financial Officer | less than a year | no data | no data | |
Principal Financial & Accounting Officer and Corporate Controller | 1.8yrs | no data | 0.016% $ 103.6k | |
Chief Technology Officer | 7.6yrs | no data | no data | |
Chief Scientific Officer | 12yrs | US$1.41m | 0.061% $ 394.7k | |
Vice President of Quality & Compliance Management | 2.8yrs | no data | no data |
4.1yrs
Average Tenure
65.5yo
Average Age
Experienced Management: 0A4C's management team is considered experienced (4.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 6.1yrs | US$5.48m | 0.41% $ 2.7m | |
Independent Chairman | 14.7yrs | US$119.68k | 0.037% $ 240.2k | |
Independent Director | 20.3yrs | US$103.68k | 0.0039% $ 25.3k | |
Independent Director | 7.6yrs | US$115.68k | 0.012% $ 79.6k | |
Independent Director | 7.6yrs | US$104.68k | 0.013% $ 83.6k | |
Independent Director | 1.8yrs | US$273.47k | 0% $ 0 | |
Independent Director | 6.3yrs | US$108.68k | 0.012% $ 77.4k | |
Member of Obesity Scientific Advisory Board | 2.4yrs | no data | no data | |
Independent Director | 4.6yrs | US$95.68k | 0% $ 0 | |
Member of Mash Scientific Advisory Board | 2.4yrs | no data | no data | |
Member of Mash Scientific Advisory Board | 2.4yrs | no data | no data | |
Member of Mash Scientific Advisory Board | 2.4yrs | no data | no data |
5.3yrs
Average Tenure
71.5yo
Average Age
Experienced Board: 0A4C's board of directors are considered experienced (5.3 years average tenure).